The firm is developing a kitted version of the four-biomarker combination test, and it plans to commercialize them in the EU and US markets.

Energy-dispersive X-ray analysis (EDX, Oxford Instruments ... Y201 hMSCs were cultured in growth medium consisting of DMEM (Thermo Fisher Scientific, Waltham, MA, USA) supplemented with 10% fetal ...

The world's most advanced early detection test for testicular cancer ? now the most common form of cancer among young men ? is being launched in the UK. The non-invasive test has exceptional ...

Thermo Fisher Scientific reported better-than-expected profit and revenue for the first quarter on Wednesday, helped by ...

Thermo Fisher Scientific shares rose Wednesday after the lab equipment and life science solutions firm reported first-quarter ...

Thermo Fisher Scientific’s proposal to build a new corporate aircraft hangar and office at Pease in Portsmouth gains approval ...

Thermo Fisher CEO Marc Casper noted strong performance in Q1 2025, delivering $10.36 billion in revenue. Adjusted EPS grew 1% to $5.15. Adjusted operating income was $2.27 billion, with an adjusted ...

Goldman Sachs analyst Matthew Sykes lowered the firm’s price target on Thermo Fisher (TMO) to $610 from $670 but keeps a Buy rating on the ...

Thermo Fisher Scientific posted 14% net-income growth in the first quarter as revenue inched up and costs remained stable. The Waltham, Mass., maker of microscopes and other life-sciences and ...

Consensus $23.25. Expands FY25 revenue view to $43.3B-$44.2B from $43.5B-$44B, consensus $43.83B. Guidance taken from Q1 earnings conference ...